cH8/1N1 LAIV

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NamecH8/1N1 LAIV
Drug Alias NameInfluenza virus vaccine (Mount Sinai School of MedicineMedicine)universal influenza virus vaccine (PATH/GSK/University of Chicago Pritzker School of Medicine/Cincinnati Children's Hospital Medical Center/Duke University School of Medicine)universal influenza virus vaccine (Mount Sinai School of Medicine)monoclonal antibodies (ContraFect)monoclonal antibodies (Mount Sinai School of Medicine)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyVaccines > Application > Prophylactic vaccine
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins modulators
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIcahn School Of Medicine At Mount Sinai
China Registration ClassN/A

Develop Information

Active CompaniesDuke University School Of MedicineGlaxosmithkline PlcPath +[6] 
Inactive CompaniesContrafect Corp
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A